Contents

Current Cancer Drug Targets, Volume 7 - Number 6

Nuclear Imaging of Hormonal Receptor Status in Breast Cancer: A Tool for Guiding Endocrine Treatment and Drug Development

, 7(6): 510 - 519

E.F. J. de Vries, M. G. Rots and G.A. P. Hospers


DOI: 10.2174/156800907781662301




Energetics of Quadruplex-Drug Recognition in Anticancer Therapy

, 7(6): 520 - 540

B. Pagano and C. Giancola


DOI: 10.2174/156800907781662257




Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches

, 7(6): 541 - 558

E. D. Warlick and B. D. Smith


DOI: 10.2174/156800907781662284




Transglutaminase-Mediated Activation of Nuclear Transcription Factor-κB in Cancer Cells: A New Therapeutic Opportunity

, 7(6): 559 - 565

Amit Verma and Kapil Mehta


DOI: 10.2174/156800907781662275




Targeting Microtubules to Inhibit Angiogenesis and Disrupt Tumour Vasculature:Implications for Cancer Treatment

, 7(6): 566 - 581

Eddy Pasquier, Nicolas Andre and Diane Braguer


DOI: 10.2174/156800907781662266




Stem Cells, Cancer, Liver, and Liver Cancer Stem Cells: Finding a Way Out of the Labyrinth...

, 7(6): 582 - 590

A. C. Piscaglia, T. D. Shupe, B. E. Petersen and A. Gasbarrini


DOI: 10.2174/156800907781662293




Cross-Talk Between the Androgen Receptor and the Phosphatidylinositol 3-Kinase/Akt Pathway in Prostate Cancer

, 7(6): 591 - 604

Yu Wang, Jeffrey I. Kreisberg and Paramita M. Ghosh


DOI: 10.2174/156800907781662248




Webmaster Contact: info@benthamscience.org
Copyright © 2018 Bentham Science